[Other] Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers |
|
This post will be closed automatically in 2026-08-29 19:52
Reward20points
|
200
[Full book]Thermal Energy Networks and Storage
20
Increasing memory lifetime of quantum low-density parity check codes with sliding-window noisy syndrome decoding
30
Beyond the quick win: rebuilding the foundations of cancer immunotherapy
20
Clinical Characteristics and Psychiatric Comorbidity of Pyromania
20
Numerical Study on Unsteady Flow of a Supersonic Partial Admission Impulse Turbine
